Article info

Download PDFPDF
Original article
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
  1. Correspondence to Dr Heinz Sill, Division of Hematology, Medical University of Graz, Auenbruggerplatz 38, A-8036 Graz, Austria; heinz.sill{at}medunigraz.at
View Full Text

Citation

Schulz E, Valentin A, Ulz P, et al
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms

Publication history

  • Received December 6, 2011
  • Revised April 11, 2012
  • Accepted May 2, 2012
  • First published May 31, 2012.
Online issue publication 
July 11, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.